Vanguard Fiduciary Trust »

Entero Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Entero Therapeutics (GRDX) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Entero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entero Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entero Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $33k 16k 2.02

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Entero Therapeutics

Federation des caisses Desjardins du Quebec
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vanguard Group
Vanguard Capital Management
Vanguard Fiduciary Trust
Jane Street
Harbour Investments
UBS Group
SBI Securities
Advisor Group Holdings
Danske Bank A/s
Citigroup

View all funds holding Entero Therapeutics